Collection of Circulating Biomarkers in Pancreatic Cancer
Protocol to Permit Collection of Circulating Biomarkers in Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
30 participants
Feb 27, 2023
OBSERVATIONAL
Conditions
Summary
This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
4 tbsp of blood in a 1-week period, occurring no more frequently than 4 times in an 8-week period
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05743049